This section is password-protected. Please enter the password to view.
← Back to Sleep Health homeA two-week Positive Airway Pressure (PAP) therapy trial is a supportive, short-term practice period designed to help you comfortably transition into using a breathing support device as the standard, long-term treatment for sleep breathing disorders, such as Obstructive Sleep Apnea (OSA).
PAP therapy is the primary treatment (often called the gold standard) for OSA and involves wearing a mask connected to a device that delivers pressurized air to keep your airway open while you sleep. Many individuals initially find it challenging to use this therapy due to difficulties like mask discomfort, claustrophobia, anxiety, or side effects from the air pressure.
A two-week trial involves taking your prescribed breathing device (like a Continuous Positive Airway Pressure or CPAP machine) home and using it nightly for about 14 days. This allows both you and your doctor to evaluate how well you tolerate the equipment and how effective the initial settings are in your typical sleeping environment.
The main goal of a focused PAP trial is to achieve patient acceptance and adherence, which significantly increases your chances of successful long-term therapy.
Improves Comfort and Acceptance: The trial provides a crucial "test drive" before starting long-term treatment. It allows you to address and resolve initial difficulties, such as fears of pressurized air or problems with mask fit, under the guidance of healthcare staff. Getting comfortable during this short trial is critical, as it can increase short-term compliance (usage of the device for more than four hours in 14 days).
Lower Upfront Costs: Compared to directly purchasing the equipment, a trial often involves lower upfront costs, particularly for sophisticated devices like those offering more complex modes of breathing support (such as Bilevel Pressure or other advanced settings). This approach allows you to confirm that the prescribed treatment works for you before making a significant financial commitment to acquire the device permanently.
During the trial, the PAP device automatically records data, which provides essential information for the doctor to ensure the treatment is working effectively.
Checks for Compliance: The doctor monitors your device usage and compliance. This allows them to quickly recognize and intervene if early signs of nonadherence appear, such as skipping two or more nights of therapy in the first week, which is a signal of potential long-term issues.
Confirms Effectiveness: The data allows the physician to assess the effectiveness of the current settings by measuring the residual level of breathing problems (residual AHI) while the device is in use.
Guides Prescription: The data confirms that the prescribed pressure achieves control of obstructive breathing. This helps the doctor finalize the correct long-term prescription.
Interested in this service or want to know if it's right for you?